IN BRIEF: Fusion Antibodies loss widens on administrative expenses
IN BRIEF: Fusion Antibodies loss widens on administrative expenses
Read moreIN BRIEF: Fusion Antibodies loss widens on administrative expenses
Read more(Sharecast News) - Contract preclinical antibody research provider Fusion Antibodies reported revenues of £2.4m in its first half on Monday, including a one-off milestone of £0.15m, which was up from £1.9m year-on-year.
Read moreTRADING UPDATES: SRT Marine Systems and ULS Technology losses widen
Read moreUK earnings, trading statements calendar - next 7 days
Read moreIN BRIEF: Fusion Antibodies signs USD1.8 million biotech contract
Read more(Sharecast News) - Preclinical antibody discovery and supply company Fusion Antibodies has signed a collaborative research and development agreement with an unnamed US-based biotechnology company which was recently incorporated to focus on a number of innovative early-stage antibody programmes, it announced on Thursday.
Read more(Sharecast News) - Antibody discovery, engineering and supply company Fusion Antibodies said on Friday that revenue growth in the current year had been consistent year-on-year, and in line with its expectations.
Read moreTRADING UPDATES: Iofina interim profit doubles on higher iodine sales
Read moreUK shareholder meetings calendar - next 7 days
Read moreTRADING UPDATES: IG Design starts year well; Ilika in Stereax progress
Read moreIN BRIEF: Fusion Antibodies shares fall after annual loss widens
Read more(Sharecast News) - Preclinical antibody discovery specialist Fusion Antibodies reported a 7% improvement in full-year revenues in its final results on Tuesday, to £4.2m.
Read moreTRADING UPDATES: Parsley Box's new meal range; Macau Property NAV down
Read more(Sharecast News) - Preclinical antibody discovery, engineering and supply company Fusion Antibodies has achieved its first research milestone payment as part of its ongoing collaboration with a major client, it announced on Friday.
Read moreTRADING UPDATES: Supreme annual revenue jumps; Pelatro in Asia deal
Read more